Medtronic CEO Omar Ishrak, speaking yesterday at LifeScience Alley's annual convention in Minneapolis, defends the pending $43 billion Covidien acquisition.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1F7Gzc9
Cap comentari:
Publica un comentari a l'entrada